Your browser doesn't support javascript.
loading
SmartFlareTM is a reliable method for assessing mRNA expression in single neural stem cells.
Diana, Andrea; Setzu, Maria Dolores; Kokaia, Zaal; Nat, Roxana; Maxia, Cristina; Murtas, Daniela.
Afiliación
  • Diana A; Department of Biomedical Sciences, University of Cagliari, Monserrato 09042, Cagliari, Italy. diana@unica.it.
  • Setzu MD; Department of Biomedical Sciences, University of Cagliari, Monserrato 09042, Cagliari, Italy.
  • Kokaia Z; Laboratory of Stem Cells & Restorative Neurology, Lund Stem Cell Center, Lund University, Lund SE-221 84, Lund, Sweden.
  • Nat R; Institute of Neuroscience, Medical University of Innsbruck, Innsbruck 6020, Austria.
  • Maxia C; Department of Biomedical Sciences, University of Cagliari, Monserrato 09042, Cagliari, Italy.
  • Murtas D; Department of Biomedical Sciences, University of Cagliari, Monserrato 09042, Cagliari, Italy.
World J Stem Cells ; 13(12): 1918-1927, 2021 Dec 26.
Article en En | MEDLINE | ID: mdl-35069990
ABSTRACT

BACKGROUND:

One of the most challenging tasks of modern biology concerns the real-time tracking and quantification of mRNA expression in living cells. On this matter, a novel platform called SmartFlareTM has taken advantage of fluorophore-linked nanoconstructs for targeting RNA transcripts. Although fluorescence emission does not account for the spatial mRNA distribution, NanoFlare technology has grown a range of theranostic applications starting from detecting biomarkers related to diseases, such as cancer, neurodegenerative pathologies or embryonic developmental disorders.

AIM:

To investigate the potential of SmartFlareTM in determining time-dependent mRNA expression of prominin 1 (CD133) and octamer-binding transcription factor 4 (OCT4) in single living cells through differentiation.

METHODS:

Brain fragments from the striatum of aborted human fetuses aged 8 wk postconception were processed to obtain neurospheres. For the in vitro differentiation, neurospheres were gently dissociated with Accutase solution. Single cells were resuspended in a basic medium enriched with fetal bovine serum, plated on poly-L-lysine-coated glass coverslips, and grown in a lapse of time from 1 to 4 wk. Live cell mRNA detection was performed using SmartFlareTM probes (CD133, Oct4, Actin, and Scramble). All the samples were incubated at 37 °C for 24 h. For nuclear staining, Hoechst 33342 was added. SmartFlareTM CD133- and OCT4-specific fluorescence signal was assessed using a semiquantitative visual approach, taking into account the fluorescence intensity and the number of labeled cells.

RESULTS:

In agreement with previous PCR experiments, a unique expression trend was observed for CD133 and OCT4 genes until 7 d in vitro (DIV). Fluorescence resulted in a mixture of diffuse cytoplasmic and spotted-like pattern, also detectable in the contacting neural branches. From 15 to 30 DIV, only few cells showed a scattered fluorescent pattern, in line with the differentiation progression and coherent with mRNA downregulation of these stemness-related genes.

CONCLUSION:

SmartFlareTM appears to be a reliable, easy-to-handle tool for investigating CD133 and OCT4 expression in a neural stem cell model, preserving cell biological properties in anticipation of downstream experiments.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: World J Stem Cells Año: 2021 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: World J Stem Cells Año: 2021 Tipo del documento: Article País de afiliación: Italia